Internal Medicine Alert (Vol. 38, No. 14) - July 30, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: July 2016

Valid through: July 2019

Target Audience

This CME activity is intended for the internist/family physician.

Subjects

  • Can a Brain Condition Affect the Heart?
  • Should Lipid Measurements Be Obtained in the Fasting or Nonfasting State?
  • Reduced Cardiac Index Is Not Correlated with Renal Function in Heart Failure Patients
  • Pharmacology Update: Sofosbuvir and Velpatasvir Tablets (Epclusa)
  • Clinical Briefs: Treatment Selection for Older Adults with Atrial Fibrillation; Sublingual Desensitization Against House Dust Mites; Updated Guidelines on Acne Management

Objectives

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • Identify cost-effective treatment regimens
  • Explain the advantages and disadvantages of new disease screening procedures.

Credit Available

Physicians

  • Maximum of 2.0 AMA PRA Category 1 Credits
  • 2.0 AOA Category 2-B credits
  • 1.0 AAFP Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Osteopathic Association has approved this continuing education activity for up to 2.0 AOA Category 2-B credits.

Internal Medicine Alert has been reviewed and is acceptable for up to 1.0 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins Jan. 1, 2016. Term of approval is for one year from this date with the option of yearly renewal.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty Listing

EDITOR

Stephen A. Brunton, MD

Adjunct Professor of Pharmacy Practice

College of Pharmacy

Roseman University of Health Sciences

Salt Lake City  

 

ASSOCIATE EDITORS

James Chan, PharmD, PhD

Pharmacy Quality and

Outcomes Manager, Kaiser

Permanente, Oakland, CA

 

William T. Elliott, MD, FACP

Chair, Formulary Committee

Northern California Kaiser

Permanente; Assistant Clinical

Professor of Medicine, University of California, San Francisco

 

Seema Gupta, MD, MSPH

Clinical Assistant Professor

Department of Family and Community Health

Joan C. Edwards School of Medicine

Marshall University

Huntington, WV

 

Harold L. Karpman, MD, FACC, FACP

Clinical Professor of Medicine

David Geffen School of Medicine

UCLA

Cardiovascular Medical Group

 

Louis Kuritzky, MD

Clinical Assistant Professor

University of Florida

Gainesville

 

Van Selby, MD

Assistant Professor of Medicine

University of California, San Francisco

Cardiology Division

Advanced Heart Failure Section

 

PEER REVIEWER

Gerald Roberts, MD

Senior Attending Physician

Long Island Jewish Medical Center

NS/LIJ Health Care System
New Hyde Park, NY

Financial Disclosure

Internal Medicine Alert’s Physician Editor Stephen Brunton, MD, is a retained consultant for Abbott Diabetes, Actavis, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Cempra, Janssen, Lilly, Merck, Novo Nordisk, Sanofi, and Teva; he serves on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Contributing Editor Louis Kuritzky, MD, is a retained consultant for AbbVie, Allergan, AstraZeneca, Janssen, Lilly, Lundbeck, Medscape, Novo Nordisk, and Sanofi Aventis; he serves on the speakers bureau of Lilly and Lundbeck. Peer Reviewer Gerald Roberts, MD; Executive Editor Leslie Coplin; and Associate Managing Editor Jonathan Springston report no financial relationships relevant to this field of study.

Drs. Chan, Elliott, Gupta, Karpman, and Selby report no financial relationships relevant to this field of study.

Copyright 2016, AHC Media. All rights reserved.